Specifically, Kaplan-Meier curves showed that high expression of NFE2L2 was significantly correlated with poor prognosis of patients in ACC (P = 0.015, HR = 1.02), LGG (P < 0.0001, HR = 1.03), PAAD (P = 0.033, HR = 1.01), and UCS (P = 0.00038, HR = 1.01) and reversely in KIRC (P < 0.0001, HR = 0.99) and SARC (P = 0.014, HR = 0.99) (Figures 4(b)–4(g)). Here, NFE2L2 is linked to adrenal cortex carcinoma.